Biotech Values

[DewDiligence]

A takeover of SHPG wouldn’t have the same kinds of political ramifications that impeded a PFE-AZN deal:

http://www.bloomberg.com/news/2014-06-20/abbvie-s-shire-push-won-t-face-pfizer-hurdles-in-takeover.html

Shire employs [fewer] than 500 people in the U.K., where its executive offices are, and only about 100 in Ireland, where the company is domiciled for tax purposes… Chief Executive Officer, Flemming Ornskov and Phil Vickers, Shire’s research head, work in the U.S.